Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase

Fertility and Sterility

Volumn 92, Issue 4, 2009, Pages 1360-1365

  von Wolff, Michael ^a   Thaler, Christian J ^b   Frambach, Torsten ^c   Zeeb, Cosima ^e   Lawrenz, Barbara ^d   Popovici, Roxana M ^a   Strowitzki, Thomas ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e Department of Gynecologic Endocrinology and Reproduction   (Switzerland)

Author keywords

Cancer; fertility preservation; luteal phase; ovarian stimulation

Indexed keywords

CETRORELIX; FOLLITROPIN; GANIRELIX; GONADORELIN ANTAGONIST; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CELL VIABILITY; CLINICAL ARTICLE; CLINICAL TRIAL; CRYOPRESERVATION; FEMALE; FERTILIZATION; FOLLICULAR ASPIRATION; FOLLICULAR PHASE; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LUTEAL PHASE; LUTEOLYSIS; MENSTRUAL CYCLE; MULTICENTER STUDY; OOCYTE; OOCYTE MATURATION; OUTCOME ASSESSMENT; OVULATION INDUCTION; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT FAILURE;

ADOLESCENT; ADULT; CRYOPRESERVATION; FEMALE; FERTILIZATION IN VITRO; HUMANS; LUTEAL PHASE; NEOPLASMS; OOCYTE RETRIEVAL; OVULATION INDUCTION; PILOT PROJECTS; PREGNANCY; PREGNANCY RATE; YOUNG ADULT; ZYGOTE;

EID: 70349446667     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.08.011     Document Type: Article

References (14)

1. Schover L.R., Rybicki L.A., Martin B.A., and Bringelsen K.A. Having children after cancer. A pilot survey of survivors' attitudes and experiences. Cancer 86 (1999) 697-709
2. Schover L.R., Brey K., Lichtin A., Lipshultz L.I., and Jeha S. Knowledge and experience regarding cancer, infertility, and sperm banking in younger male survivors. J Clin Oncol 20 (2002) 1880-1889
3. Lee S.J., Schover L.R., Partridge A.H., Patrizio P., Wallace W.H., Hagerty K., et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24 (2006) 2917-2931
4. Madrigrano A., Westphal L., and Wapnir I. Egg retrieval with cryopreservation does not delay breast cancer treatment. Am J Surg 194 (2007) 477-481
5. Fertiprotekt. Network for fertility preservation before chemo- and radiotherapy. Available at: http://www.fertiprotekt.eu. Accessed 15 March 2008.
6. Anderson R.A., Kinniburgh D., and Baird D.T. Preliminary experience of the use of a gonadotrophin-releasing hormone antagonist in ovulation induction/in-vitro fertilization prior to cancer treatment. Hum Reprod 14 (1999) 2665-2668
7. Fridén B.E., and Nilsson L. Gonadotrophin-releasing hormone-antagonist luteolysis during the preceding mid-luteal phase is a feasible protocol in ovarian hyperstimulation before in vitro fertilization. Acta Obstet Gynecol Scand 84 (2005) 812-816
8. Humaidan P., Bungum L., Bungum M., Hald F., Agerholm I., Blaabjerg J., et al. Reproductive outcome using a GnRH antagonist (cetrorelix) for luteolysis and follicular synchronization in poor responder IVF/ICSI patients treated with a flexible GnRH antagonist protocol. Reprod Biomed Online 11 (2005) 679-684
9. Menezo Y. Cryopreservation of IVF embryos: which stage?. Eur J Obstet Gynecol Reprod Biol 113 Suppl 1 (2004) S28-S32
10. Deutsches IVF-Register. Available at: http://www.deutsches-ivf-register.de. Accessed 15 March 2008.
11. Niswender G.D., Juengel J.L., Silva P.J., Rollyson M.K., and McIntush E.W. Mechanisms controlling the function and life span of the corpus luteum. Physiol Rev 80 (2000) 1-29
12. Zeleznik A.J. In vivo responses of the primate corpus luteum to luteinizing hormone and chorionic gonadotropin. Proc Natl Acad Sci U S A 95 (1998) 11002-11007
13. Del Canto F., Sierralta W., Kohen P., Muñoz A., Strauss III J.F., and Devoto L. Features of natural and gonadotropin-releasing hormone antagonist-induced corpus luteum regression and effects of in vivo human chorionic gonadotropin. J Clin Endocrinol Metab 92 (2007) 4436-4443
14. Azim A.A., Costantini-Ferrando M., Lostritto K., and Oktay K. Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer patients undergoing ovarian stimulation before in vitro fertilization. J Clin Endocrinol Metab 92 (2007) 2197-2200